Aminolevulinate Dehydratase (ALAD) (N-Term) Peptid
Kurzübersicht für Aminolevulinate Dehydratase (ALAD) (N-Term) Peptid (ABIN8094535)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- N-Term
-
Verwendungszweck
- ALAD Peptide - N-terminal region
-
Sequenz
- MPPTSSTPSL SRPGLGQAGK PDTGSHPPPT ISTSIFLSCF PTIPLSRPRT
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-ALAD Antibody(ARP41845_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- ALAD (Aminolevulinate Dehydratase (ALAD))
-
Hintergrund
-
Background Information: The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 Molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway, zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria.
Alternative Symbols: ALADH, MGC5057, PBGS
-
Molekulargewicht
- 39kDa
-
Gen-ID
- 210
-
NCBI Accession
- NP_001003945
Target
-